pharmaceutical investing Verona Pharma plc Operational Update and Financial Results for the First Quarter Ended March 31, 2018
medical device investing AIT Therapeutics Receives Patent Allowance for Delivery of Inhaled Nitric Oxide at Concentrations of at Least 160ppm for Treatment of Bronchiolitis in Infants
pharmaceutical investing Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554
QIMC Announces Thermogenic Wet-Gas Signature in 86% of Soil-Gas Samples at New Salem-Apple River, Nova Scotia, Next to Its 30% Clean Hydrogen Discovery
Standard Uranium Initiates Partner Funded Surface Exploration Program at the Corvo Uranium Project, Eastern Athabasca Basin, Saskatchewan
Brixton Metals Drills 4 m of 1,975 g/t Silver within 23.50 m of 348 g/t Silver in Hole 449 at its Langis Project in Ontario
